Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) - Pipeline Review, H2 2016
"Free
Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or
FFAR1) - Pipeline Review, H2 2016"
The Report covers current Market Trends, Analysis, Forecast, Review,
Share, Size, Growth, Effect.
Description-
Summary
Global
Markets Directs, Free Fatty Acid Receptor 1 (G Protein Coupled
Receptor 40 or GPR40 or FFAR1) - Pipeline Review, H2 2016, provides
in depth analysis on Free Fatty Acid Receptor 1 (G Protein Coupled
Receptor 40 or GPR40 or FFAR1) targeted pipeline therapeutics.
The
report provides comprehensive information on the Free Fatty Acid
Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1),
targeted therapeutics, complete with analysis by indications, stage
of development, mechanism of action (MoA), route of administration
(RoA) and molecule type. The report also covers the descriptive
pharmacological action of the therapeutics, its complete research and
development history and latest news and press releases. Additionally,
the report provides an overview of key players involved in Free Fatty
Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1)
targeted therapeutics development and features dormant and
discontinued projects.
Scope
-
The report provides a snapshot of the global therapeutic landscape
for Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or
GPR40 or FFAR1)
-
The report reviews Free Fatty Acid Receptor 1 (G Protein Coupled
Receptor 40 or GPR40 or FFAR1) targeted therapeutics under
development by companies and universities/research institutes based
on information derived from company and industry-specific sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
Reasons
to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand the targeted therapy areas and indications
for Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or
GPR40 or FFAR1)
-
Identify the use of drugs for target identification and drug
repurposing
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
Comments
Post a Comment